Page last updated: 2024-11-05

thalidomide and Anti-Phospholipid Antibody Syndrome

thalidomide has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tektonidou, MG1
Vlachoyiannopoulos, PG1
Pagnoux, C1
Lutz-Zarrouk, V1
Michel, M1
Schaeffer, A1
Godeau, B1

Other Studies

2 other studies available for thalidomide and Anti-Phospholipid Antibody Syndrome

ArticleYear
Antiphospholipid syndrome triggered by thalidomide in a patient with discoid lupus erythematosus.
    Lupus, 2003, Volume: 12, Issue:9

    Topics: Adult; Antiphospholipid Syndrome; Humans; Immunosuppressive Agents; Lupus Erythematosus, Discoid; Ma

2003
Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide.
    Lupus, 2004, Volume: 13, Issue:6

    Topics: Aged; Anticoagulants; Antiphospholipid Syndrome; Humans; Immunosuppressive Agents; International Nor

2004